Bayer
BAYN
Delayed Frankfurt - 11/17 05:35:03 pm
107.55EUR
-0.32%
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 20162017
Sales46 76936 530
EBITDA11 3029 888
Operating profit (EBIT)9 8297 676
Pre-Tax Profit (EBT)5 8876 126
Net income4 5316 066
EPS ( € )5,447,14
Dividend per Share ( € )2,702,59
Yield2,72%2,40%
Announcement Date02/22/2017
06:57am
-
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 20162017
Debt11 77810 022
Finance--
Operating income (EBITDA)11 3029 888
Leverage
(Debt/EBITDA)
1,04x1,01x
Capital Expenditure2 5782 006
Book Value Per Share (BVPS)36,7 €39,5 €
Cash Flow per Share9,92 €10,1 €
Announcement Date02/22/2017
06:57am
-
Balance Sheet Analysis
Financial Ratios
Size 2017e 2018e
Capitalization 88 938 M€ -
Entreprise Value (EV) 98 960 M€ 102 591 M€
Valuation 2017e 2018e
P/E ratio (Price / EPS) 15,1x 18,5x
Capitalization / Revenue 2,43x 2,30x
EV / Revenue 2,71x 2,65x
EV / EBITDA 10,0x 9,40x
Yield (DPS / Price) 2,40% 2,56%
Price to book (Price / BVPS) 2,72x 2,55x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 21,0% 22,3%
operating Leverage (Delta EBIT / Delta Sales) -1,00x 2,08x
Net Margin (Net Profit / Revenue) 16,6% 12,7%
ROA (Net Profit / Asset) 9,33% 7,38%
ROE (Net Profit / Equities) 17,9% 15,5%
Rate of Dividend 36,2% 47,2%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   5,49% 5,36%
Cash Flow / Sales 22,9% 19,1%
Capital Intensity (Assets / Sales) 1,78x 1,72x
Financial Leverage (Net Debt / EBITDA) 1,01x 1,25x
Price Earning Ratio
BNA & Dividende